Mitochondrial Complex IV (Cytochrome c Oxidase) Deficiency, Nuclear-Type

name: Mitochondrial Complex IV Deficiency
display_name: Mitochondrial Complex IV (Cytochrome c Oxidase) Deficiency, Nuclear-Type
creation_date: "2026-06-13T00:00:00Z"
description: >-
  A group of autosomal recessive disorders affecting nuclear-encoded components required for cytochrome c oxidase
  (complex IV) biogenesis or function. Most members have demonstrated assembly-factor, cofactor, structural-subunit
  or mitochondrial gene-expression defects that impair terminal electron transfer and oxidative phosphorylation.
  Dominant organ involvement varies. COX4I2-related EPIDACH is included through its affected structural/regulatory
  subunit and clinical disease association; patient tissue-specific assembly failure has not been demonstrated,
  and normal lactate and fibroblast COX activity were reported.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PATHWAY
grouping_rationale: >-
  The grouping covers disorders converging on nuclear-encoded complex IV biogenesis or function. Most members
  conform to the complex_iv_assembly_deficiency module. COX4I2-related EPIDACH is retained as an explicitly
  identified structural/regulatory-subunit disorder with incomplete evidence for the downstream biochemical
  lesion, rather than asserting assembly-module conformance. Distinct gene defects and dominant clinical manifestations
  justify separate Disease entries. The criteria define the curated union of module-conforming disorders and
  the COX4I2-associated recessive syndrome; membership does not imply that every member has lactic acidosis,
  neurologic disease, or a measured assembly defect.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0033885
      label: mitochondrial complex IV deficiency, nuclear-type
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      The grouping concept corresponds to the MONDO "mitochondrial complex IV
      deficiency, nuclear-type" class. exactMatch records the intended
      conceptual alignment; current DisMech coverage and clinical-syndrome MONDO
      placements are consistency signals, not reasons to weaken the mapping
      predicate.
    consistency:
    - reference: MONDO
      consistent: CONSISTENT
      notes: >-
        Most listed members are is-a descendants of MONDO:0033885 (including
        COX6B1-Related COX Deficiency -> MONDO:0033637, nuclear type 7;
        COX20-Related COX Deficiency -> MONDO:0033645, nuclear type 11;
        COX11-Related COX Deficiency -> MONDO:0859520, nuclear type 23;
        COX16-Related COX Deficiency -> MONDO:0859160, nuclear type 22;
        PET100-Related COX Deficiency -> MONDO:0033646, nuclear type 12;
        COX14-Related COX Deficiency -> MONDO:0033639, nuclear type 10;
        COX5A-Related COX Deficiency -> MONDO:0033655, nuclear type 20;
        COX4I1-Related COX Deficiency -> MONDO:0033651, nuclear type 16; and
        TACO1-Related COX Deficiency -> MONDO:0033638, nuclear type 8). The four
        exceptions (SCO2-Related Fatal Infantile Cardioencephalomyopathy ->
        MONDO:0011451; COX15-Related COX Deficiency -> MONDO:0014051;
        COX4I2-Related Pancreatic Insufficiency-Anemia-Hyperostosis Syndrome ->
        MONDO:0012992; COA5-Related Fatal Infantile Cardioencephalomyopathy ->
        MONDO:0014667) are genuine nuclear-encoded complex IV
        assembly/cofactor/structural-subunit defects whose dismech
        entries map to clinical-presentation MONDO terms rather than to a
        "nuclear type N" node. Treat these outside-subtree members as
        MONDO/member-alignment signals, while treating uncurated MONDO
        nuclear-type complex IV deficiency descendants as DisMech curation gaps.
membership_criteria:
- description: >-
    A member either conforms to the complex IV biogenesis-failure module or is the COX4I2-associated structural/regulatory-subunit
    disorder included on clinical and genetic evidence.
  criteria_semantics: NECESSARY_AND_SUFFICIENT
  logic:
    operator: OR
    operands:
    - criterion_predicate: CONFORMS_TO_MODULE
      module: complex_iv_assembly_deficiency#Complex IV Biogenesis Failure
      description: Conforms to the complex IV biogenesis-failure node of the assembly module.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: COX4I2
        term:
          id: hgnc:16232
          label: COX4I2
      description: >-
        COX4I2-associated EPIDACH: retained without asserting an experimentally established patient complex
        IV assembly defect.
members:
- member: SURF1-Related Leigh Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      SURF1 is required for early complex IV holoenzyme assembly; its loss is the
      most common cause of complex IV-deficient Leigh syndrome (subacute
      necrotizing encephalomyelopathy).
    gene:
      preferred_term: SURF1
      term:
        id: hgnc:11474
        label: SURF1
- member: SCO2-Related Fatal Infantile Cardioencephalomyopathy
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      SCO2 is a copper metallochaperone for the CuA site; its loss produces a
      cardiac-dominant phenotype (fatal infantile hypertrophic
      cardioencephalomyopathy), distinguishing it from the brain-dominant SURF1
      phenotype.
    gene:
      preferred_term: SCO2
      term:
        id: hgnc:10604
        label: SCO2
- member: SCO1-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      SCO1, the paralogous copper chaperone, causes a phenotype with hepatic and
      encephalopathic involvement, contrasting with the cardiac emphasis of SCO2.
    gene:
      preferred_term: SCO1
      term:
        id: hgnc:10603
        label: SCO1
- member: COX10-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX10 catalyzes the first step of heme a biosynthesis (farnesylation);
      defects impair heme a delivery to complex IV, with leukodystrophy and
      tubulopathy phenotypes.
    gene:
      preferred_term: COX10
      term:
        id: hgnc:2260
        label: COX10
- member: COX15-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX15 catalyzes the final heme a synthesis step; its loss causes
      heme a-deficient complex IV with cardiomyopathy and Leigh-like
      encephalopathy.
    gene:
      preferred_term: COX15
      term:
        id: hgnc:2263
        label: COX15
- member: COX18-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX18 mediates membrane insertion/export of the COX2 C-terminus; defects
      impair maturation of the mitochondrially encoded core subunit.
    gene:
      preferred_term: COX18
      term:
        id: hgnc:26801
        label: COX18
- member: COA8-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COA8 stabilizes the assembling complex IV against oxidative stress; its
      loss gives a complex IV deficiency with a notably variable, sometimes
      slowly progressive course.
    gene:
      preferred_term: COA8
      term:
        id: hgnc:20492
        label: COA8
- member: TACO1-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      TACO1 is a mitochondrial mRNA translational activator specific for the
      mtDNA-encoded COX I (MT-CO1) core subunit; its loss selectively impairs
      COX I synthesis (a translational, rather than assembly/cofactor, lesion)
      and produces a notably mild, late-onset, basal ganglia-predominant Leigh
      phenotype.
    gene:
      preferred_term: TACO1
      term:
        id: hgnc:24316
        label: TACO1
- member: COX6B1-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX6B1 is a nuclear-encoded structural subunit with roles in early
      MT-CO2 maturation or incorporation and late complex IV stability.
      Pathogenic variants can impair stable incorporation despite preserved
      total protein, or markedly reduce protein abundance. The spectrum
      includes neonatal encephalomyopathy with hydrocephalus and hypertrophic
      cardiomyopathy and childhood-onset cavitating leukodystrophy
      (MC4DN7, MONDO:0033637).
    gene:
      preferred_term: COX6B1
      term:
        id: hgnc:2280
        label: COX6B1
- member: COX20-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX20 is an inner-membrane chaperone for the mitochondrially encoded core
      subunit COX2; it stabilizes newly synthesized COX2 and presents it to the
      SCO1/SCO2 copper-metallation module, so its loss stalls assembly at a
      COX2-deficient subassembly. Distinctively, the phenotype is a comparatively
      slowly progressive neurological disorder — hypotonia, cerebellar ataxia,
      dysarthria, dystonia, and sensory-predominant axonal neuropathy — rather
      than fatal infantile cardioencephalomyopathy (MC4DN11, MONDO:0033645).
    gene:
      preferred_term: COX20
      term:
        id: hgnc:26970
        label: COX20
- member: COX11-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX11 is the copper metallochaperone that delivers copper to the CuB
      centre of the core subunit COX1, complementary to the SCO1/SCO2
      metallochaperones that metallate the CuA centre of COX2 — so it completes
      the copper-delivery picture for the holoenzyme. Its loss causes an
      infantile-onset mitochondrial encephalopathy (with Leigh-like features in
      a later case), and the patient-fibroblast ATP deficit is distinctively
      rescuable by coenzyme Q10 (MC4DN23, MONDO:0859520).
    gene:
      preferred_term: COX11
      term:
        id: hgnc:2261
        label: COX11
- member: PET100-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      PET100 is a small mitochondrial inner-membrane chaperone acting at an
      intermediate stage of holoenzyme assembly, forming a subcomplex with the
      COX subunits and promoting their incorporation; its loss leaves the
      subunits unstable and blocks assembly of fully formed Complex IV.
      Distinctively, the same gene spans a Lebanese founder mutation presenting
      as complex IV-deficient Leigh syndrome with prominent seizures and a
      truncating variant causing fatal neonatal lactic acidosis with multiorgan
      involvement (MC4DN12, MONDO:0033646).
    gene:
      preferred_term: PET100
      term:
        id: hgnc:40038
        label: PET100
- member: COX14-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX14 (formerly C12orf62) is a very small (~6 kDa) single-pass inner-membrane
      factor that couples synthesis of the mtDNA-encoded core subunit COX I
      (MT-CO1) to early holoenzyme assembly; its loss uncouples COX I synthesis
      from assembly, leaving the nascent enzyme complex unstable. Distinctively,
      the lesion sits at the synthesis-assembly coupling step (contrasting with
      the copper/heme-cofactor and later-assembly defects of other members) and
      was first identified in an index subject with severe congenital lactic
      acidosis, dysmorphic features, and a fatal neonatal course (MC4DN10,
      MONDO:0033639).
    gene:
      preferred_term: COX14
      term:
        id: hgnc:28216
        label: COX14
- member: COX5A-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX5A is a nuclear-encoded structural subunit with a role in complex IV
      biogenesis. The founding p.Arg107Cys allele is predicted to disturb the
      COX5A/COX4 interface; patient fibroblasts accumulate the COX1 S1 assembly
      intermediate but retain some mature enzyme. Those siblings had infantile
      pulmonary arterial hypertension, lactic acidemia and growth failure.
      A later p.Ile89Ser patient had growth failure, ketotic hypoglycemia and
      hypergonadotropic hypogonadism without cardiovascular involvement.
      Copper increased residual complex IV abundance in founding patient
      fibroblasts without clearing the assembly intermediate; clinical efficacy
      has not been established (MC4DN20, MONDO:0033655).
    gene:
      preferred_term: COX5A
      term:
        id: hgnc:2267
        label: COX5A
- member: COX4I1-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX4I1 encodes the ubiquitous common isoform of cytochrome c oxidase
      subunit 4 (COX4-1), a nuclear-encoded *structural*/regulatory subunit whose
      loss destabilizes the holoenzyme directly (one of the few structural-subunit
      defects, like COX6B1, rather than an assembly factor or metallochaperone).
      Distinctively, the respiratory-chain defect drives elevated reactive oxygen
      species and increased chromosomal breakage that simulated Fanconi anemia in
      the index case, while a second family showed an encephalopathic Leigh-like
      phenotype — spanning a growth-failure/genomic-instability presentation and a
      neurodegenerative one (MC4DN16, MONDO:0033651).
    gene:
      preferred_term: COX4I1
      term:
        id: hgnc:2265
        label: COX4I1
- member: COX8A-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX8A is a nuclear-encoded structural subunit whose loss destabilizes free
      complex IV, while residual enzyme can persist in respiratory supercomplexes.
      The reported splice-acceptor variant causes abnormal RNA and a Leigh syndrome
      spectrum presentation with leukodystrophy and severe epilepsy. ClinGen's
      March 2024 assessment remained Limited because only one clinical case was
      included (MC4DN15, MONDO:0033650).
    gene:
      preferred_term: COX8A
      term:
        id: hgnc:2294
        label: COX8A
- member: COA3-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COA3 (CCDC56) is a small inner-membrane Complex IV assembly factor that,
      together with COX14, couples synthesis of the mtDNA-encoded core catalytic
      subunit COX1 with its incorporation into the holoenzyme; the two factors are
      mutually interdependent (each is undetectable when the other is lost).
      Distinctively, the founding patient followed an unusually mild,
      adult-compatible course — sensorimotor peripheral neuropathy, exercise
      intolerance, obesity, and short stature — rather than the early-fatal
      encephalopathy/cardiomyopathy of most members, underscoring the
      tissue-specific expression of the COX1-coupling assembly defect
      (MC4DN14, MONDO:0033649).
    gene:
      preferred_term: COA3
      term:
        id: hgnc:24990
        label: COA3
- member: PET117-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      PET117 is a small nuclear-encoded Complex IV assembly factor; biallelic
      loss-of-function (a homozygous nonsense variant in the founding sibling
      pair) abolishes functional Pet117 and yields an isolated Complex IV
      deficiency with reduced steady-state COX subunit levels, rescued by
      lentiviral re-expression of wild-type PET117 in patient fibroblasts.
      Distinctively, an earlier proposed copper-insertion role for Pet117 could
      not be confirmed in patient cells, and the presentation is a Leigh-like
      brainstem-predominant phenotype — neurodevelopmental regression with
      medulla oblongata lesions on MRI — rather than the cardiomyopathy or
      peripheral-neuropathy presentations of other members (MC4DN19,
      MONDO:0033654).
    gene:
      preferred_term: PET117
      term:
        id: hgnc:40045
        label: PET117
- member: COX6A2-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX6A2 is a nuclear-encoded structural subunit of complex IV whose
      pathogenic missense variants destabilize the protein and impair assembly
      and supercomplex formation. The founding patients had congenital limb
      and facial myopathy with hypotonia, with cardiomyopathy in one. COX6A2
      is enriched in striated muscle but is also expressed in cortical
      interneurons. Later neuronal and cardiomyocyte models show context-specific
      bioenergetic and functional defects; bulk ATP can remain preserved in
      knockout mouse heart and skeletal muscle (MC4DN18, MONDO:0033653).
    gene:
      preferred_term: COX6A2
      term:
        id: hgnc:2279
        label: COX6A2
- member: COXFA4-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COXFA4 (formerly NDUFA4) encodes a structural complex IV subunit that
      supports late enzyme maturation and activity. Biallelic splice variants
      and gene-overlapping deletions impair stable mature enzyme accumulation,
      while core assemblies can still form. COXFA4L2 partly compensates in
      tested patient cells. The clinical spectrum includes developmental and
      movement disorders, white-matter disease, lactic acidosis and variable
      cardiac involvement, with both adult survival and early deaths reported;
      some individuals lack established Leigh syndrome. This distinguishes
      MC4DN21 (MONDO:0033656) from the congenital myopathy reported in the founding COX6A2 cases.
    gene:
      preferred_term: COXFA4
      term:
        id: hgnc:7687
        label: NDUFA4
- member: FASTKD5-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      FASTKD5 is an endonuclease required for mitochondrial RNA processing at
      noncanonical junctions, upstream of translation and complex IV assembly.
      Residual-function patient fibroblasts preferentially lose mature CO1 RNA,
      CO1 translation and assembled complex IV, while complete-knockout models
      also lose CYB translation and complex III assembly. Muscle combined-enzyme
      assays can show broader abnormalities than fibroblasts. Reported Leigh
      syndrome spectrum presentations range from severe infantile disease to
      childhood developmental delay and adult-onset movement and ocular findings;
      the small founding series does not establish a reliable severity predictor.
    gene:
      preferred_term: FASTKD5
      term:
        id: hgnc:25790
        label: FASTKD5
- member: COX16-Related COX Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX16 is a small intermembrane-space-facing assembly factor in the
      copper-delivery route of the COX2 module: it interacts with newly
      synthesized COX2 and the copper-center metallochaperones (SCO1, SCO2,
      COA6) and is implicated in CuA-site formation. Its loss stalls assembly at
      a COX2-deficient subassembly and abolishes the holoenzyme (rescued by
      wild-type COX16 re-expression), placing the lesion in the same
      copper-delivery pathway as the SCO1/SCO2 and COX20 members. Distinctively,
      the first two reported patients (homozygous c.244C>T, p.Arg82*) presented
      with hypertrophic cardiomyopathy, encephalopathy, severe fatal neonatal
      lactic acidosis, and liver dysfunction (MC4DN22, MONDO:0859160).
    gene:
      preferred_term: COX16
      term:
        id: hgnc:20213
        label: COX16
- member: COA5-Related Fatal Infantile Cardioencephalomyopathy
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COA5 (formerly C2orf64, the orthologue of yeast Pet191) is a small
      twin-CX9C assembly factor whose lesion sits at the transition between
      MTCO1 maturation and MTCO2 incorporation - one step earlier than the
      SCO1/SCO2/COX16/COX20 copper-delivery members, and distinct from the
      heme a (COX10, COX15) and structural-subunit defects. Patient cells
      accumulate an MTCO1-containing subcomplex that never acquires MTCO2, and
      complexome profiling of a COA5 knockout places the defect precisely at
      that step. Distinctively, the whole reported disease is three patients in
      two Turkish families homozygous for one missense allele
      (c.157G>C, p.Ala53Pro), with a cardiac-dominant neonatal phenotype -
      hypertrophic cardiomyopathy with a non-compaction appearance - and no
      documented central nervous system lesion, despite the
      "cardioencephalomyopathy" in the disease name (CEMCOX3/MC4DN9,
      MONDO:0014667). Like SCO2-Related Fatal Infantile Cardioencephalomyopathy,
      COX15-Related COX Deficiency and COX4I2-Related Pancreatic
      Insufficiency-Anemia-Hyperostosis Syndrome, its dismech entry maps to a
      clinical-presentation MONDO term rather than to a "nuclear type N" node.
    gene:
      preferred_term: COA5
      term:
        id: hgnc:33848
        label: COA5
- member: COA6-Related Fatal Infantile Cardioencephalomyopathy
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COA6 (formerly C1orf31) is a twin-CX9C intermembrane-space protein in the
      copper-delivery arm, alongside SCO1, SCO2, COX16 and COX17 - but its role
      within that arm is distinct from theirs. Its best-supported role is as a
      thiol-disulfide oxidoreductase that reduces the copper-coordinating
      disulfides of SCO1, SCO2 and COX2, which is the step that lets copper be
      loaded into the CuA centre in the oxidizing intermembrane space. The lesion
      is therefore a failure to prepare the copper-accepting cysteines rather
      than a failure to deliver copper, which separates it from the
      metallochaperone members and from the earlier assembly block in COA5.
      Whether COA6 also carries copper itself is unsettled and should not be
      asserted either way here: it binds copper in vitro and a metallochaperone
      role has been proposed. The COA6 entry's
      `coa6_reductase_versus_metallochaperone` discussion carries both sides. Loss
      of COA6 causes fast turnover of unmetallated COX2 and accumulation of a
      monomeric COX1 intermediate. Copper supplementation is a documented rescue
      - complete in yeast coa6-null cells and partial in patient fibroblasts - as
      it is for the SCO2 and COX5A members of this arm; unlike SCO2, whose
      copper-histidine lead has been given to a patient, no copper has been
      administered to a COA6 patient. The
      reported phenotype is neonatal hypertrophic cardiomyopathy with death in
      infancy, and, as for COA5, no central nervous system lesion is documented
      despite the "cardioencephalomyopathy" in the disease name (CEMCOX4/MC4DN13,
      MONDO:0014668). Whether the enzyme defect is isolated to Complex IV or also
      involves Complex I is contested in the literature.
    gene:
      preferred_term: COA6
      term:
        id: hgnc:18025
        label: COA6
- member: COX4I2-Related Pancreatic Insufficiency-Anemia-Hyperostosis Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      COX4I2 encodes a tissue-regulated structural/regulatory isoform of complex IV subunit 4. The E138K-associated
      syndrome includes pancreatic insufficiency, dyserythropoietic anemia and variable calvarial hyperostosis;
      hypotonia and developmental delay also occur. Patient fibroblasts show reduced transcript abundance and
      attenuated cobalt-induced expression but normal COX activity. Pancreatic acinar enrichment is inferred
      from whole-pancreas/islet RNA comparisons; patient assembly failure and ATP depletion were not demonstrated.
      The member is included through the explicit COX4I2 criterion rather than assumed module conformance.
    gene:
      preferred_term: COX4I2
      term:
        id: hgnc:16232
        label: COX4I2
notes: >-
  Most members have nuclear-encoded assembly-factor or metallochaperone defects. Structural subunits, the TACO1
  translational activator and FASTKD5 RNA-processing factor provide additional routes to complex IV dysfunction.
  COX4I2 is a distinct evidence case: the clinical/genetic association and altered transcript response are
  established observations, while the tissue-specific bioenergetic, erythroid and osteoclast mechanisms remain
  proposed. Its inclusion must not be read as proof of lactic acidosis, a non-neurological phenotype, or direct
  holoenzyme destabilization in affected patient tissues.